Skip to main content
. 2021 Sep 14;11:135. doi: 10.1186/s13613-021-00922-5

Table 2.

Primary and secondary outcomes

Outcomes NIV
(N = 110)
HFNC
(N = 112)
Relative risk
(95% CI)
P
Primary outcomes, No. (%)
 Reintubation at 72 h 20 (18.2) 20 (17.9) 0.99 (0.70–1.39) 0.95
Secondary outcomes, No. (%)
 Reintubation at 7 days 30 (27.3) 24 (21.4) 0.86 (0.64–1.14) 0.31
 Reintubation at 28 days 40 (36.4) 37 (33.0) 0.93 (0.71–1.22) 0.6
 Reintubation in ICU 37 (33.6) 33 (29.5) 0.91 (0.69–1.19) 0.5
 Extubation failure at 72 h 34 (30.9) 27 (24.1) 0.85 (0.64–1.12) 0.26
 Extubation failure in ICU 47 (42.7) 37 (33.0) 0.82 (0.63–1.06) 0.14
Mortality
 ICU mortality 12 (10.9) 6 (5.4) 0.72 (0.51–1.03) 0.13
 28-day mortality 10 (9.1) 8 (7.1) 0.88 (0.57–1.37) 0.59
 In-hospital mortality 26 (23.6) 24 (21.4) 0.94 (0.69–1.28) 0.69
Length of stay, median (IQR), days
 ICU length of stay 10 (6–22) 10 (6–19) 0.68
 Hospital length of stay 24 (14–44) 28 (19–48) 0.23